Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens

Arbekacin sulfate (ABK), an aminoglycoside antibiotic, was discovered in 1972 and was derived from dibekacin to stabilize many common aminoglycoside modifying enzymes. ABK shows broad antimicrobial activities against not only Gram-positive bacteria including methicillin-resistant Staphylococcus aure...

Descripción completa

Detalles Bibliográficos
Autor principal: Matsumoto, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186621/
https://www.ncbi.nlm.nih.gov/pubmed/25298740
http://dx.doi.org/10.2147/CPAA.S44377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186621/
https://www.ncbi.nlm.nih.gov/pubmed/25298740
http://dx.doi.org/10.2147/CPAA.S44377

Ejemplares similares